GlassScriptPhysician profile
Julie Ramos
NPI 1275567000
$8,128.24
in general payments reported to CMS, 2019-2025
31 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,099 · 2020: $615 · 2021: $1,419 · 2022: $790 · 2023: $2,885 · 2024: $1,131 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,485 · Travel and Lodging: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,484.58 |
| Travel and Lodging | $720.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,237.12 | 2020-2025 | Watchman Access System, Watchman Flx, Varithena Administration Pack |
| Abbott Laboratories | $1,149.99 | 2023-2025 | Aveir, Jot Dx, Gallant |
| Novartis Pharmaceuticals Corporation | $741.57 | 2019-2024 | |
| Cardiovascular Systems INC. | $428.15 | 2019 | |
| Esperion Therapeutics, INC. | $397.48 | 2021-2023 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $385.67 | 2020-2023 | Farxiga, Brilinta |
| Janssen Pharmaceuticals, INC | $382.07 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $370.98 | 2019-2025 | Lifevest |
| Amgen INC. | $348.32 | 2019-2024 | Repatha |
| Impulse Dynamics (USA) INC. | $277.50 | 2021-2025 | Optimizer |
| Inari Medical, INC. | $230.36 | 2022 | |
| Cardiofocus, INC. | $149.11 | 2023 | Heartlight System |
| Medtronic Vascular, INC. | $128.71 | 2019-2020 | |
| Edwards Lifesciences Corporation | $115.19 | 2022 | |
| Novo Nordisk INC | $113.63 | 2021-2023 | Ozempic |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $108.63 | 2020-2021 | |
| Pfizer INC. | $93.90 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.82 | 2020-2023 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $55.88 | 2023 | Inpefa |
| Terumo Medical Corporation | $55.55 | 2019 | |
| Merck Sharp & Dohme LLC | $45.34 | 2021 | |
| Biocompatibles, INC. | $45.05 | 2019 | |
| Medtronic, INC. | $40.54 | 2021 | |
| Abiomed | $24.61 | 2024 | Impella |
| Bard Peripheral Vascular, INC. | $23.93 | 2024 | Venclose Maven Catheter |
| Philips North America LLC | $22.60 | 2023 | |
| Astellas Pharma US INC | $18.01 | 2021 | |
| Kestra Medical Technology Services, INC. | $18.00 | 2023 | Assure Wcd |
| Tactile Systems Technology INC | $13.59 | 2020 | |
| Bardy Diagnostics, INC. | $13.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.94 | 2023 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Ramos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.